← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Promiliad Biopharma, Inc.
Alberton, MT
$7,487,883
Total funding
13
Grants
Funding over time
peak $1.5M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,487,883 · 13
By mechanism
R42$5,460,166 · 4
R41$1,342,758 · 6
R43$684,959 · 3
Investigators at Promiliad Biopharma, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Potent Antifolates as New Therapeutics for MRSA$763,661
R42 · FY2011 · AI
Potent Antifolates as New Therapeutics for MRSA$754,203
R42 · FY2010 · AI
Single application thixotropic antibiotic delivery systems for otitis externa$751,069
R42 · FY2020 · DC
Novel antibacterial agents derived from natural products$750,375
R42 · FY2020 · AI
Novel antibacterial agents derived from natural products$746,516
R42 · FY2019 · AI
Single application thixotropic antibiotic delivery systems for otitis externa$696,062
R42 · FY2021 · DC
Natural feedstocks for diversity-oriented synthesis$517,214
R42 · FY2006 · GM
Natural feedstocks for diversity-oriented synthesis$481,066
R42 · FY2007 · GM
Single application thixotropic antibiotic delivery systems for otitis externa$297,825
R41 · FY2018 · DC
Novel antibacterial agents derived from natural products$295,729
R41 · FY2016 · AI
Development of stable isosteres of dihydrofolate reductase inhibitors as antibact$287,766
R43 · FY2013 · AI
Potent and selective DHFR inhibitors for treating Cryptosporidiosis$279,271
R41 · FY2006 · AI
Isoindolinones as Antimicrobial Agents$225,624
R43 · FY2008 · AI
The identification of novel negative allosteric modulators of the nicotinic recep$190,807
R41 · FY2009 · DA
New antibiotics targeting fatty acid biosynthesis$171,569
R43 · FY2009 · AI
Fermentation initiated antibiotic synthesis$137,162
R41 · FY2005 · AI
Natural feedstocks for diversity oriented synthesis$100,024
R41 · FY2004 · GM
The identification of novel negative allosteric modulators of the nicotinic recep$41,940
R41 · FY2009 · DA